Richard Doubleday, EVP Chief Commercial Officer at DEXCOM INC (DXCM), sold 2,578 shares at $427.36 ($1.1M) on 2020-07-23, disclosed to the SEC on 2020-07-27.
Seasonal sale ($1.1M) by EVP Chief Commercial Officer — this insider has traded DXCM in July in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $421.62 | 200 | $84K | 7.6% |
| 2 | $424.63 | 83 | $35K | 3.2% |
| 3 | $425.99 | 94 | $40K | 3.6% |
| 4 | $427.36 | 476 | $203K | 18.4% |
| 5 | $427.36 | 476 | $203K | 18.4% |
| 6 | $428.52 | 107 |
| $46K |
| 4.2% |
| 7 | $429.60 | 571 | $245K | 22.2% |
| 8 | $429.60 | 571 | $245K | 22.2% |
| Total | $427.82 avg | 2,578 | $1.1M | 100% |
| Filing → |
| DXCM | SELL | 2021-01-25 | $815K | — | Filing → |
| DXCM | SELL | 2021-01-06 | $8.1M | — | Filing → |
| DXCM | SELL | 2020-12-28 | $661K | — | Filing → |